Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

KZR Stock Annual Income Statement. Download in Excel

Kezar Life Sciences Inc. logo

Kezar Life Sciences Inc.

Sector: Healthcare   

Industry: Biotechnology

7.41
 
USD
  
-0.06
  
(-0.80%)
Previous close: 7.47  Open: 7.4  Bid: 7.37  Ask: 7.6
52 week range    
5.20   
   11.35
Mkt Cap: 54 M  Avg Vol (90 Days): 96,578
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Tuesday 3rd December 2024

Stock Rankings

40
MarketXLS Rank
60
Value
38
Technical
23
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

KZR Income Statement

Annual
Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-18.4-9.5-10.4-10.1-1.4
Basic EPS total-18.4-9.5-10.4-10.1-1.4
Basic weighted shares outstanding1 M2 M4 M5 M7 M73 M
Depreciation-700000.0900000.0900000.0900000.01000000.01 M
DepreciationAndAmortization-700000.0900000.0900000.0900000.01000000.01 M
Diluted EPS total-22.6-18.4-9.5-10.4-10.1-1.4
Diluted normalized net income/share-22.6-10.1-1.4
Diluted weighted shares outstanding1 M2 M4 M5 M7 M73 M
GeneralAndAdministrativeExpense7 M10 M12 M16 M20 M27 M
Gross operating profit7 M
ImpairmentOfCapitalAssets3 M
Income before tax-23 M-35 M-42 M-55 M-68 M-102 M
Income restructuring and M&A6 M
Interest income2 M2 M1 M188000.04 M11 M
InterestExpenseNonOperating159000.01 M2 M
Net income from total operations-23 M-35 M-42 M-55 M-68 M-102 M
NetIncomeCommonStockholders-23 M-35 M-42 M-55 M-68 M-102 M
NetIncomeContinuousOperations-23 M-35 M-42 M-55 M-68 M-102 M
NetNonOperatingInterestIncomeExpense2 M2 M1 M29000.03 M10 M
Normalized income-69 M
Operating income-25 M-37 M-43 M-55 M-71 M-111 M
Operating income before depreciation (EBITDA)-23 M-35 M-40 M-53 M-66 M-99 M
OperatingExpense25 M37 M43 M55 M71 M112 M
Other income net-6 M
OtherGandA7 M10 M12 M16 M20 M27 M
OtherImpairmentOfCapitalAssets3 M
OtherOperatingExpenses-25 M37 M-487000.0-775000.0-1 M-2 M
RentAndLandingFees-1000000.01 M1 M1 M2 M
Research & development expense18 M27 M31 M39 M51 M86 M
ResearchExpense18 M27 M31 M39 M51 M86 M
RestructringAndMnAIncome6 M
SalariesAndWages-2 M
Selling Gen & administrative expense7 M10 M12 M16 M20 M27 M
Special income/charges-6 M
Total Income available for interest expense (EBIT)-23 M-35 M-42 M-54 M-67 M-100 M
Total common shares outstanding2 M4 M5 M6 M7 M73 M
Total net income-23 M-35 M-42 M-55 M-68 M-102 M
Total ordinary shares7 M7 M7 M7 M7 M7 M
Total revenues7 M
TotalExpenses25 M37 M43 M55 M71 M112 M
TotalRevenue7 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University